0001209191-20-001639.txt : 20200106
0001209191-20-001639.hdr.sgml : 20200106
20200106150806
ACCESSION NUMBER: 0001209191-20-001639
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200102
FILED AS OF DATE: 20200106
DATE AS OF CHANGE: 20200106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wilson Jason Douglas
CENTRAL INDEX KEY: 0001662395
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37785
FILM NUMBER: 20509322
MAIL ADDRESS:
STREET 1: C/O REATA PHARMACEUTICALS, INC.
STREET 2: 2801 GATEWAY DR. SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001358762
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113651945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5320 LEGACY DRIVE
CITY: PLANO
STATE: TX
ZIP: 75024
BUSINESS PHONE: 972-865-2219
MAIL ADDRESS:
STREET 1: 5320 LEGACY DRIVE
CITY: PLANO
STATE: TX
ZIP: 75024
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-02
0
0001358762
REATA PHARMACEUTICALS INC
RETA
0001662395
Wilson Jason Douglas
5320 LEGACY DRIVE
PLANO
TX
75024
0
1
0
0
Executive VP of Operations
Employee Stock Option (right to buy)
207.20
2020-01-02
4
A
0
15000
0.00
A
2030-01-02
Class B common stock
15000
15000
D
The options vest in sixteen equal quarterly installments beginning on April 2, 2020, subject to continued service through each vesting date.
The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
/s/ Tracy Herson, attorney-in-fact
2020-01-06